Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Finasteride reduces hair growth and is safe for women with excessive hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Men can report their own balding patterns well enough for large health studies.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Topical finasteride helps regrow hair and reduce balding without side effects.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.